{
  "pmcid": "5441224",
  "sha256": "edd5b0666821590648e0121b9890873930f2fc2bd33785755dd2dca58ef0d141",
  "timestamp_utc": "2025-11-09T22:46:29.954917+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.004447895100075,
    "reading_ease": 20.992717391304353,
    "word_count": 207
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "CALGB 140503: A Randomised Controlled Trial Comparing Sub-lobar Resection to Lobectomy for Stage IA NSCLC"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "multi-center randomised controlled trial evaluating the equivalence of sub-lobar resection and lobectomy for stage IA non-small cell lung cancer (NSCLC) ≤ 2 cm in diameter"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were eligible if they had suspected stage IA NSCLC ≤ 2 cm"
      },
      "Intervention": {
        "score": 2,
        "evidence": "evaluating the equivalence of sub-lobar resection and lobectomy"
      },
      "Objective": {
        "score": 1,
        "evidence": "evaluating the equivalence of sub-lobar resection and lobectomy for stage IA non-small cell lung cancer (NSCLC)"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was overall survival, measured over a 5-year period"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment ensured by sealed envelopes"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable due to the nature of the surgical interventions"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "From June 15, 2007, to March 22, 2013, 637 patients were preregistered across multiple centers"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Of the 637 preregistered patients, 389 were randomised (61%)"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "Preoperative biopsy significantly increased randomisation rates (p<0.001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events related to randomisation were reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial is registered under NCT00499330"
      },
      "Funding": {
        "score": 1,
        "evidence": "funded by the National Cancer Institute"
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}